Abstract:Epidemiologic and clinical features of Kawasaki Disease (KD) strongly support an infectious etiology. KD is worldwide, most prominently in Japan, Korea, and Taiwan, reflecting increased genetic susceptibility among Asian populations. In Hawaii, KD rates are 20-fold higher in Japanese ethnics than in Caucasians, intermediate in other ethnicities. The age distribution of KD, highest in children < 2 yo, lower in those < 6 months, is compatible with infection by a ubiquitous agent resulting in increasing immunity with age and with transplacental immunity, as with some classic viruses. The primarily winter-spring KD seasonality and well-documented Japanese epidemics with wave-like spread also support an infectious trigger. We hypothesize KD pathogenesis involves an RNA virus that usually causes asymptomatic infection but KD in a subset of genetically predisposed children. CD8 T cells, oligoclonal IgA, and upregulation of cytotoxic T cell and interferon pathway genes in the coronaries in fatal KD also support a viral etiology. Cytoplasmic inclusion bodies in ciliated bronchial epithelium identified by monoclonal antibodies made from oligoclonal IgA heavy chains also supports a viral etiology. Recent availability of "second generation" antibodies from KD peripheral blood plasmablasts may identify a specific viral antigen. Thus, we propose an unidentified ("new") RNA virus infects bronchial epithelium usually causing asymptomatic infection but KD in a subset of genetically predisposed children. The agent persists in inclusion bodies, with intermittent respiratory shedding, entering the bloodstream via macrophages targeting coronaries. Antigen-specific IgA plasma cells and CD8 T cells respond but coronaries can be damaged. IVIG may include antibody against the agent. Post infection, 97-99% of KD patients are immune to the agent, protected against recurrence. The agent can spread either from those with asymptomatic primary infection in winter-spring or from a previously infected contact who intermittently sheds the agent.

Regulatory T cells and Kawasaki disease

Changes in CD_(69),CD_(25) and HLA-DR Expressions in Peripheral Blood T Cells in Kawasaki Disease

Progress in etiology and pathophysiology of Kawasaki disease

Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease

The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease.

The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease

[Recent research on platelet-leukocyte aggregates and their role in the pathogenesis of Kawasaki disease].

The Epidemiology and Pathogenesis of Kawasaki Disease

Insights Into Coronary Artery Lesions in Kawasaki Disease

Kawasaki disease: pathophysiology and insights from mouse models

Preventing coronary artery lesions in Kawasaki disease

Study Progress of Coronary Artery Damage in Kawasaki Disease

Characterization of the T Cell Response to Lactobacillus casei Cell Wall Extract in Children With Kawasaki Disease and Its Potential Role in Vascular Inflammation

Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.

The up‐to‐date pathophysiology of Kawasaki disease

Identification of susceptibility genes for Kawasaki disease

Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients

The Clinical Diagnosis and Management of Kawasaki Disease: a Review and Update

Kawasaki Disease and Coronary Artery Involvement: A Narrative Review

Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis

Single-Cell Transcriptome Reveals Potential Mechanisms for Coronary Artery Lesions in Kawasaki Disease